Motor neuron disorder simulating ALS induced by chronic inhalation of pyrethroid insecticides
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Some agricultural chemicals are known to be neurotoxic. Pyrethroid insecticides are commonly used as they are highly toxic to a wide range of insects but have low toxicity to mammals. However, overexposure to pyrethroids can induce various neurotoxic symptoms such as numbness, seizure, tremor, and memory impairment.1 Such symptoms are usually transient, and there are no reports indicating that chronic intoxication from pyrethroid insecticides causes motor neuron damage, although a case of pathologically proven motor neuron death after acute massive ingestion of pesticides containing pyrethroids and organochlorine has been reported.2 Here, we report a case of slowly progressive motor neuron disease (MND) following chronic exposure to pyrethroids that was indistinguishable from ALS.
Case report.
A 44-year-old woman, a food shop proprietor, had been using cans of pyrethroid insecticides containing imiprothrin, phenotorin, d-T80-resmethrin, and d-T80-phthalthrin almost every day for 3 years in an unventilated room. Initially, she experienced tongue numbness, nausea, and rhinitis while using …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Fabricio Ferreira de Oliveira and Dr. Alan Cronemberger Andrade
► Watch
Related Articles
- No related articles found.
Topics Discussed
Alert Me
Recommended articles
-
Articles
Impaired motor cortex inhibition in patients with amyotrophic lateral sclerosisEvidence from paired transcranial magnetic stimulationUlf Ziemann, Martin Winter, Carl D. Reimers et al.Neurology, November 01, 1997 -
Articles
Transcranial magnetic stimulation identifies upper motor neuron involvement in motor neuron diseaseW.J. Triggs, D. Menkes, J. Onorato et al.Neurology, August 01, 1999 -
Article
Effects of subthalamic nucleus stimulation on motor cortex plasticity in Parkinson diseaseSang Jin Kim, Kaviraja Udupa, Zhen Ni et al.Neurology, July 08, 2015 -
Articles
Transcranial magnetic stimulation in ALSUtility of central motor conduction testsA. G. Floyd, Q. P. Yu, P. Piboolnurak et al.Neurology, February 09, 2009